Moving towards the optimal treatment of chronic hepatitis C

Italian Journal of Gastroenterology and Hepatology

Volumn 29, Issue 1, 1997, Pages 69-74

  Camma, C ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Chronic hepatitis C; Interferon; Optimal treatment

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIVIRUS AGENT; INTERFERON; RIBAVIRIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHRONIC HEPATITIS; CLINICAL FEATURE; DRUG EFFICACY; GENOTYPE; HEALTH CARE COST; HEPATITIS C; HEPATITIS NON A NON B; HUMAN; LIVER CIRRHOSIS; LONG TERM CARE; SIDE EFFECT; VIREMIA;

ANTIVIRAL AGENTS; CHRONIC DISEASE; DRUG THERAPY, COMBINATION; HEPATITIS C; HUMANS; INTERFERONS; RIBAVIRIN;

EID: 0031466977     PISSN: 11258055     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Tinè F, Magrin S, Craxi A, Pagliaro L. Interferon for non-A, nonB chronic hepatitis. A meta-analysis of randomised clinical trials. J Hepatol 1991; 13:192-199.
2. Tong MJ, EI-Farra NS, Reikes AR, Co RL. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 1995:332:1463-1466.
3. Shindo M, Arai K, Sokawa Y, Okuno T. Hepatic hepatitis C virus RNA as a predictor of a long-term response to interferon-a therapy. Ann Intern Med 1995;122:586-591.
4. Chemello L, Albert! A, Rose K, Simmonds P. Hepatitis C serotype and response to Interferon therapy. W Engl J Med 1994;330:143.
5. Magrin S, Craxi A, Fabiano C, Simonetti RG, Fiorentino G, Marino L, Diquattro O, Di Marco V, Lo lacono O, Volpes R, Almasio P, Urdea MS, Neuwald P, Sanchez-Pescador R, Detmer J, Wilber JC, Pagliaro L. Hepatitis C viremia in chronic liver disease: Relationship to interferon-a or corticosteroid treatment. Hepatology 1994;19:273-279.
6. Pagliaro L, Craxi A, Gamma C, Tine F, Di Marco V, Lo lacono O, Almasio P. Interferon-a for chronic hepatitis C: An analysis of pre-treatment clinical predictors of response. Hepatology 1994:19:820-828.
7. Nishiguchi S, Kuroki T, Nakatani S, Morimoto H, Takeda T, Nakajima S, Shiomi S, Seki S, Kobayashi K, Otani S. Randomised trial of effects of interferon-a on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis. Lancet 1995:346:1051-1055.
8. Craxî A, Di Marco V, Almasio PL Hepatic hepatitis C virus RNA in chronic hepatitis C. Ann Intern Med 1996:124:72.
9. Poynard T, Bedossa P, Chevallier M, Mathurin P, Lemonnier C, Trepo C, Couzigou P, Payen JL, Sajus M, Costa JM, Vidaud M,
10. Chaput JC, and the Multicenter Study Group. A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. N Engl J Med 1995:332:14571462.
11. Serfaty L, Chazouillières O, Pawlotsky JM, Andreani T, Pellet C, Poupon R. Interferon alfa therapy in patients with chronic hepatitis C and persistently normal aminotransferase activity. Gastroenterology 1996; 110:291-295.
12. Fattovich G, Giustina G, Favarato S, Ruol A, Macarri G, Orlandi F, laquinto G, Ambrosone L, Francavilla A, Pastore G, Santantonio MT, Romagno D, Bolondi L, Sofia S, Marchesini A, Pisi E, Mazzella G, Roda E, Attaro L, Chiodo F, Mori F, Verucchi G, Lanzini A, Salmi A. A survey of adverse events in 11,241 patients with chronic viral hepatitis treated with alfa interferon. J Hepatol 1996;24:38-47.
13. Janssen HLA, Brouwer JT, Nevens F, Sanchez-Tapias JM, Craxî A, Hadziyannis S. Fatal hepatic decompensation associated with interferon alfa. BMJ 1993:306:107-108.
14. Romeo R, Pol S, Berthelot P, Brechot C. Eradication of hepatitis C virus RNA after alpha-interferon therapy. Ann Intern Med 1994;121:276-277.
15. Reichard O, Andersson J, Schvarcz R, Weiland O. Ribavirin treatment for chronic hepatitis C. Lancet 1991:337:1058-1061.
16. Di Bisceglie AM, Shindo M, Fong T-L, Fried MW, Swain MG, Bergasa NV, Axiotis CA, Waggoner JG, Park Y, Hoofnagle JH. A pilot study of ribavirin therapy for chronic hepatitis C. Hepatology 1992:16:649-654.
17. Camps J, Garcia N, Riezu-Boj JI, Civeira MP, Prieto J. Ribavirin in the treatment of chronic hepatitis C unresponsive to alfa interferon. J Hepatol 1993:19:408-412.
18. Di Bisceglie AM, Conjeevaram HS, Fried MW, Sallie R, Park Y, Yurdaydin C, Swain M, Kleiner DE, Mahaney K, Hoofnagle JH, Wright D. Ribavirin as therapy for chronic hepatitis C - A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1995:123:897-903.
19. Dusheiko G, Main J, Thomas H, Reichard O, Lee C, Dhillon A, Rassam S, Fryden A, Reesink H, Bassendine M, Norkrans G, Cuypers T, Lelie N, Telfer P, Watson J, Weegink C, Sillikens P, Weiland O. Ribavirin treatment for patients with chronic hepatitis C: Results of a placebo-controlled study. J Hepatol 1996:25:591-598.
20. Bizollon T, Adahm M, Ducerf C, Baulieux J, Trepo C. New approaches to treatment of recurrent hepatitis C virus following liver transplantation using ribavirin. Transpl Proc 1996:28:28422843.
21. Reichard O, Yun Z-B, Sönnerborg A, Weiland O. Hepatitis C viral RNA titers in serum prior to, during, and after oral treatment with ribavirin for chronic hepatitis C. J Med Virol 1993 ;41:99-102.
22. Koskinas J, Tibbs C, Saleh MG, Pereira LMMB, McFarlane IG, Williams R. Effects of ribavirin on intrahepatic and extrahepatic expression of hepatitis C virus in interferon non-responsive patients. J Med Virol 1995;45:29-34.
23. Kakumu S, Yoshioka K, Wakita T, Ishikawa T, Takayanagi M, Higashi Y. A pilot study of ribavirin and interferon beta for the treatment of chronic hepatitis C. Gastrocnlerology 1993;105:507-512.
24. Brillanti S, Garson J, Foli M, Whitby K, Deaville R, Masci C, Miglioli M, Barbara L. A pilot study of combination therapy with ribavirin plus interferon alfa for interferon alfa-resistant chronic hepatitis C. Gastroenterology 1994; 107:812-817.
25. Braconier JH, Paulsen O, Engman K, Widell A. Combined alphainterferon and ribavirin treatment in chronic hepatitis C: A pilot study. Scand J Infec Dis 1995;27:325-329.
26. Brillanti S, Miglioli M, Barbara L. Combination antiviral therapy with ribavirin and interferon alfa in interferon alfa relapsers and non-responders: Italian experience. J Hepalol 1995;23 (Suppl. 2):13-16.
27. Chemello L, Cavalletto L, Bernardinello E, Guido M, Pontisso P, Alberti A. The effect of interferon alfa and ribavirin combination therapy in naive patients with chronic hepatitis C. J Hepatol 1995;23 (Suppl. 2):8-12.
28. Schvarcz R, Ando Y, Sönnerborg A, Weiland O. Combination treatment with interferon alfa-2b and ribavirin for chronic hepatitis C in patients who have failed to achieve sustained response to interferon alone: Swedish experience. J Hepatol 1995;23 (Suppl. 2):17-21.
29. Schvarcz R, Yun ZB, Sönnerborg A, Weiland O. Combined treatment with interferon alpha-2b and ribavirin for chronic hepatitis C in patients with a previous non-response or non-sustained response to interferon alone. J Med Virol 1995;46:43-47.
30. Reichard O, Norkrans G, Fryden A, et al. Interferon-alpha and ribavirin versus interferon alpha alone as therapy for chronic hepatitis C - a randomized double-blind placebo-controlled study. Hepatology 1996;24:356A.
31. Andreone P, Cursaro C, Gramenzi A et al. A randomized controlled trial of leukocytic IFN alfa vs leukocytic IFN alfa plus ribavirin in chornic hepatitis C resistant to a previous recombinant or lymphoblastoid IFN treatment. 1997 AISF Meeting, Rome (in press).
32. Lai MY, Kao JH, Yang PM, Wang JT, Chen PJ, Chan KW, Chu JS, Chen DS. Long-term efficacy of ribavirin plus interferon alfa in the treatment of chronic hepatitis C. Gastroenterology 1996;111:1307-1312.
33. Schalm SW, Brouwer JT, Chemello L, Alberti A, Bellobuono A, Ideo G, Schwartz R, Weiland O. Interferon-ribavirin combination therapy for chronic hepatitis C. Dig Dis Sei 1996;41 (Suppl.):131S-134S.